G Medical Innovations Holdings Limited
G Medical Innovations Holdings Limited Stock, NASDAQ:GMVD
G Medical Innovations Holdings Ltd. engages in the development of mobile and e-health solutions and monitoring service platforms. It operates through the following segments: Products, Patient Services, and Covid-19 Testing. The Products segment includes the development, manufacture, and marketing of trans-telephonic and wireless diagnostic equipment for the medical industry and consumer market. The Petient Services segment comprises cardiac monitoring services of MCT, Patch, Event, Extended Holter, and Pacemaker. The Covid -19 Testing segment covers three kinds of diagnostic tests which are Rapid Antigen + A/B Flu Combo test, PCR test, and Antibody test. The company was founded in August 2014 and is headquartered in George Town, Cayman Islands.